| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 1099 |
| 1 | ALTEPLASE | 1031 |
| 2 | ASPIRIN | 746 |
| 3 | ASPIRIN 325 MG | 704 |
| 4 | ASPIRIN 81 MG | 704 |
| 5 | AMLODIPINE | 512 |
| 6 | ACETAMINOPHEN | 496 |
| 7 | FUROSEMIDE | 466 |
| 8 | OMEPRAZOLE MAGNESIUM | 461 |
| 9 | PREDNISONE | 460 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALTEPLASE | 1031 | 0.0686 |
| 1 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 16 | 0.0277 |
| 2 | CAPLACIZUMAB | 49 | 0.0275 |
| 3 | STANNOUS FLUORIDE | 18 | 0.0250 |
| 4 | AMINOCAPROIC ACID | 19 | 0.0237 |
| 5 | SODIUM MONOFLUOROPHOSPHATE | 8 | 0.0216 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 40 | 0.0144 |
| 7 | ANTI-INHIBITOR COAGULANT COMPLEX | 13 | 0.0118 |
| 8 | TOREMIFENE CITRATE | 5 | 0.0116 |
| 9 | POTASSIUM NITRATE, SODIUM FLUORIDE | 7 | 0.0109 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 1631 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1450 |
| 2 | Corticosteroid [EPC] | 974 |
| 3 | Kinase Inhibitor [EPC] | 799 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 769 |
| 5 | Proton Pump Inhibitor [EPC] | 604 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 592 |
| 7 | Benzodiazepine [EPC] | 581 |
| 8 | Vitamin C [EPC] | 527 |
| 9 | Calcium Channel Blocker [EPC] | 512 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 414 | 0.0139 |
| 1 | Human Antihemophilic Factor [EPC] | 2 | 0.0130 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 19 | 0.0092 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 106 | 0.0070 |
| 4 | Factor Xa Inhibitor [EPC] | 1631 | 0.0059 |
| 5 | Antifibrinolytic Agent [EPC] | 55 | 0.0056 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 95 | 0.0049 |
| 7 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 8 | Tricyclic Antidepressant [EPC] | 2 | 0.0042 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 4 | 0.0032 |